LAMI, FEDERICO
LAMI, FEDERICO
DIPARTIMENTO DI SCIENZE DELL'AMBIENTE E DELLA TERRA (DEPARTMENT OF EARTH AND ENVIRONMENTAL SCIENCES - DISAT)
Validating Natural Compounds as Toll-Like Receptor 4 (TLR4) Antagonists: Experimental Challenges and Therapeutic Perspectives
2026 Lami, F; Romerio, A; Valle-Gomez, L; Martin-Camara, O; Martin-Santamaria, S; Peri, F
Design and synthesis of a new Toll Like Receptor 4 agonist-based Antibody Drug Conjugate for cancer immunotherapy
2025 Lami, F; Italia, A; Romerio, A; Franco, A; Artusa, V; Shaik, M; Facchini, F; Gotri, N; Luraghi, A; Minotti, A; Cochet, F; Martin-Santamaria, S; D'Amico, G; Peri, F
Design, synthesis and biological evaluation of a new Toll Like Receptor 4 agonist-based Antibody Drug Conjugate for cancer immunotherapy.
2025 Lami, F; Romerio, A; D'Amico, G; Peri, F
Design, synthesis and biological evaluation of a new Toll Like Receptor 4 agonist-based Antibody Drug Conjugate for cancer immunotherapy.
2025 Lami, F; Romerio, A; D'Amico, G; Peri, F
Design, synthesis and biological evaluation of a new Toll Like Receptor 4 agonist-based Antibody Drug Conjugate for cancer immunotherapy.
2025 Lami, F; Romerio, A; D'Amico, G; Peri, F
Developing New Toll-Like Receptor 4 (TLR4) Modulators As Innovative And Inexpensive Vaccine Adjuvants
2025 Romerio, A; Shaik, M; Italia, A; Lami, F; Galimberti, M; Peri, F
Functional impact of Toll-like Receptor 4 (TLR4) modulation in lung fibrosis-associated fibroblasts
2025 Italia, A; Romerio, A; Lami, F; Sarcinelli, G; Lenoci, M; Galli, M; Granucci, F; Costa, B; Lovisa, S; Peri, F
Study on the impact of Toll-like Receptor 4 (TLR4) modulation in rare inflammatory-fibrotic diseases
2025 Italia, A; Franco, A; Shaik, M; Romerio, A; Lami, F; Lovisa, S; Peri, F; Costa, B
Towards more efficient synthetic immunomodulators: biological characterization and mechanism of action of monosaccharide-derived TLR4 agonists
2025 Franco, A; Aladailleh, Z; Romerio, A; Italia, A; Lami, F; Shaik, M; Skupinska, N; Artusa, V; Pirianov, G; Peri, F
Design, Synthesis and characterization of synthetic and natural derived TLR4 antagonists
2024 Lami, F; Romerio, A; Italia, A; Shaik, M; Martin-Santamaria, S; Peri, F
Developing New Toll-Like Receptor 4 (TLR4) Modulators as Innovative and Inexpensive Vaccine Adjuvants
2024 Romerio, A; Shaik, M; Italia, A; Lami, F; Peri, F
Study on the impact of Toll-like Receptor 4 (TLR4) modulation in rare inflammatory-fibrotic diseases
2024 Italia, A; Franco, A; Shaik, M; Romerio, A; Lami, F; Lovisa, S; Peri, F; Costa, B
Design, synthesis and Biological evaluation of New, glycolipid-based Toll-Like Receptor 4 (TLR4) Modulators
2023 Romerio, A; Franco, A; Shaik, M; Lami, F; Benivegna, G; Scalvini, S; Peri, F
DESIGN, SYNTHESIS AND BIOLOGICAL EVALUATION OF NEW, GLYCOLIPID-BASED TOLL-LIKE RECEPTOR 4 (TLR4) MODULATORS
2023 Romerio, A; Franco, A; Artusa, V; Shaik, M; Lami, F; Peri, F
Overcoming Challenges in Chemical Glycosylation to Achieve Innovative Vaccine Adjuvants Possessing Enhanced TLR4 Activity
2023 Romerio, A; Franco, A; Shadrick, M; Shaik, M; Artusa, V; Italia, A; Lami, F; Demchenko, A; Peri, F